ZEB2 and intrahepatic cholangiocarcinoma: For example, miR-590-3p reduced migration, invasion and EMT in glioblastoma multiforme by targeting ZEB1 and ZEB2 [13], and in intrahepatic cholangiocarcinoma by targeting ZEB2 [41].